MARKET

PPBT

PPBT

Purple Biotech Ltd
NASDAQ
1.450
-0.030
-2.03%
Opening 13:42 09/25 EDT
OPEN
1.480
PREV CLOSE
1.480
HIGH
1.540
LOW
1.400
VOLUME
23.29K
TURNOVER
--
52 WEEK HIGH
14.10
52 WEEK LOW
1.160
MARKET CAP
2.36M
P/E (TTM)
-0.0518
1D
5D
1M
3M
1Y
5Y
1D
H.C. Wainwright Remains a Buy on Purple Biotech (PPBT)
TipRanks · 4d ago
Weekly Report: what happened at PPBT last week (0914-0918)?
Weekly Report · 4d ago
Weekly Report: what happened at PPBT last week (0907-0911)?
Weekly Report · 09/14 09:45
Purple Biotech Shareholders Approve All AGM Proposals, File Results with U.S. SEC
TipRanks · 09/09 20:28
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 09/08 21:06
Weekly Report: what happened at PPBT last week (0831-0904)?
Weekly Report · 09/07 09:42
3 Penny Stocks on Investors’ Radar after Big Moves, 9/03/26
TipRanks · 09/03 11:31
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 09/02 17:06
More
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Webull offers Purple Biotech Ltd - ADR stock information, including NASDAQ: PPBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PPBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PPBT stock methods without spending real money on the virtual paper trading platform.